Clearmind Medicine (NASDAQ:CMND) Posts Quarterly Earnings Results

Clearmind Medicine (NASDAQ:CMND) posted its quarterly earnings data on Wednesday. The company reported ($0.11) earnings per share for the quarter, Zacks reports.

Clearmind Medicine Stock Down 1.3 %

Shares of CMND stock traded down $0.02 on Friday, hitting $1.47. 7,496 shares of the company’s stock traded hands, compared to its average volume of 233,105. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71. Clearmind Medicine has a one year low of $0.95 and a one year high of $2.30. The company’s fifty day simple moving average is $1.40 and its 200 day simple moving average is $1.41.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.